Discuss This Drug

EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

CHEBI:CHEBI_747801

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

pharm_class_moa
Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
pharm_class
Non-Nucleoside Analog [EXT]
pharm_class_epc
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
pharm_class_cs
Nucleosides [CS]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
active_ingredient_name
EFAVIRENZ
rxcui
643066
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20241231
route
ORAL
marketing_category
DRUG FOR FURTHER PROCESSING
dosage_form
TABLET, FILM COATED
active_ingredient_strength
600 mg/1
nui
N0000009948
unii
JE6H2O27P8
marketing_start_date
20060720
package_marketing_start_date
20-JUL-06
labeler_name
Cipla USA Inc.
manufacturer_name
Cipla USA Inc.
generic_name
efavirenz, emtricitabine and tenofovir disoproxil fumarate
product_ndc
63285-019
spl_id
8d8919f7-af6b-473d-a703-fad9cc43c31d
package_ndc
63285-019-00
package_description
6263 TABLET, FILM COATED in 1 CONTAINER (63285-019-00)
brand_name
efavirenz, emtricitabine and tenofovir disoproxil fumarate
brand_name_base
efavirenz, emtricitabine and tenofovir disoproxil fumarate
application_number
ANDA206894
spl_set_id
a7d94a1c-31b0-4272-8f8d-186d580e16e0
upc
0369097210021